These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22018182)

  • 1. Prednisone chronotherapy.
    Spies CM; Cutolo M; Straub RH; Burmester GR; Buttgereit F
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S42-5. PubMed ID: 22018182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis.
    Alten R
    Expert Rev Clin Immunol; 2012 Feb; 8(2):123-33. PubMed ID: 22288450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F; Naty S; Bruno C; Grembiale RD
    Rev Recent Clin Trials; 2017; 12(2):124-128. PubMed ID: 28356031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
    Kirwan JR; Buttgereit F
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian use of glucocorticoids in rheumatoid arthritis.
    Cutolo M; Sulli A; Pincus T
    Neuroimmunomodulation; 2015; 22(1-2):33-9. PubMed ID: 25227591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.
    Buttgereit F; Kent JD; Holt RJ; Grahn AY; Rice P; Alten R; Yazici Y
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):168-77. PubMed ID: 26535595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythms in rheumatology--a glucocorticoid perspective.
    Spies CM; Straub RH; Cutolo M; Buttgereit F
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25608777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Ann Rheum Dis; 2010 Jul; 69(7):1275-80. PubMed ID: 20542963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F; Gibofsky A
    Expert Opin Pharmacother; 2013 Jun; 14(8):1097-106. PubMed ID: 23594208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Lancet; 2008 Jan; 371(9608):205-14. PubMed ID: 18207016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids and chronotherapy in rheumatoid arthritis.
    Cutolo M
    RMD Open; 2016; 2(1):e000203. PubMed ID: 27042335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronobiology and the treatment of rheumatoid arthritis.
    Cutolo M
    Curr Opin Rheumatol; 2012 May; 24(3):312-8. PubMed ID: 22410544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2).
    Buttgereit F; Mehta D; Kirwan J; Szechinski J; Boers M; Alten RE; Supronik J; Szombati I; Romer U; Witte S; Saag KG
    Ann Rheum Dis; 2013 Feb; 72(2):204-10. PubMed ID: 22562974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythms and rheumatoid arthritis.
    Cutolo M
    Joint Bone Spine; 2019 May; 86(3):327-333. PubMed ID: 30227223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis.
    Kirwan JR; Clarke L; Hunt LP; Perry MG; Straub RH; Jessop DS
    Ann N Y Acad Sci; 2010 Apr; 1193():127-33. PubMed ID: 20398018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should impaired morning function in rheumatoid arthritis be treated?
    Buttgereit F
    Scand J Rheumatol Suppl; 2011; 125():28-39. PubMed ID: 21529308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches.
    Alten R; Wiebe E
    Neuroimmunomodulation; 2015; 22(1-2):83-8. PubMed ID: 25228310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids.
    Cutolo M; Iaccarino L; Doria A; Govoni M; Sulli A; Marcassa C
    Clin Exp Rheumatol; 2013; 31(4):498-505. PubMed ID: 23415134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C
    Drug Des Devel Ther; 2016; 10():1047-58. PubMed ID: 27022244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():26-9. PubMed ID: 23259655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.